STL Index for: Photopheresis

Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada

Results from multiple studies have shown promising response rates, and extracorporeal photopheresis has an overall excellent safety profile with very few adverse events reported.

Therapeutic Advances in Cutaneous T-Cell Lymphoma

A variety of novel therapeutic modalities have recently become available for patients with cutaneous T cell lymphoma (CTCL). Here, we offer a brief overview of these agents and discuss their place in the spectrum of current therapies for CTCL.

Advances in Pemphigus Therapy

The pemphigus variants represent a group of potentially life-threatening autoimmune mucocutaneous blistering diseases. Herein, we focus on the new and emerging therapies in the management of pemphigus.

ECP versus PUVA for the Treatment of Cutaneous T-Cell Lymphoma

Extracorporeal photopheresis (ECP) and psoralen plus ultraviolet A therapy (PUVA) are widely accepted types of photochemotherapy used for the treatment of cutaneous T-cell lymphomas (CTCL). The best efficacy data derived from prospective case studies and meta-analysis are reviewed here.

POPULAR

Advertisement